David Apelian

David Apelian is currently the Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. He previously served as the Chief Executive Officer & Director at BlueSphere Bio, Inc. from 2019 to 2022.
Prior to that, he held positions at Bristol Myers Squibb Co. as the Clinical Director-Infectious Diseases Group from 2002 to 2004, and at Schering-Plough Corp.
as the Clinical Director-Hepatology Department from 1999 to 2002.
From 2013 to 2017, he was the Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. He also served as the Chief Medical Officer, SVP-Research & Development at GlobeImmune, Inc. from 2008 to 2013.
Additionally, he held a position as Vice President at Wyeth Pharmaceuticals LLC.
Dr. Apelian holds a doctorate degree from the University of Medicine & Dentistry of New Jersey, undergraduate and doctorate degrees from Rutgers State University of New Jersey, and an MBA degree from Quinnipiac University.